181 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety and Efficacy of Primaquine for P. Vivax
Condition: Malaria
Interventions: Drug: Primaquine;   Drug: delayed primaquine
22 Recruiting Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Condition: Chagas Disease With Heart Failure
Intervention: Drug: Aspirin
23 Unknown  Time to Infection With Malaria Parasites
Condition: Plasmodium Falciparum Malaria
Intervention:
24 Recruiting Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Intervention: Drug: Eurartesim tablets
25 Unknown  ANC & Malaria Diagnostic in Pregnancy
Condition: Malaria
Intervention: Drug: ASAQ
26 Unknown  Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana
Conditions: Malaria;   Anaemia
Interventions: Drug: Artemether-lumefantrine combination;   Drug: Dihydroartemisinin Piperaquine combination;   Drug: Amodiaquine plus sulphadoxine-pyrimethamine combination
27 Recruiting An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Condition: Malaria
Intervention: Procedure: Blood sampling
28 Unknown  Malaria Prevalence in Children
Condition: Plasmodium Falciparum Malaria
Intervention:
29 Recruiting Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis
Conditions: Malaria;   Plasmodium Falciparum Malaria
Interventions: Biological: PfSPZ Challenge;   Biological: 0.9% Sodium Chloride (Placebo)
30 Unknown  BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease
Conditions: Chagas Disease;   Trypanosomiasis;   Heart Disease
Interventions: Drug: Benznidazole;   Drug: Placebo
31 Recruiting Novel Use Of Hydroxyurea in an African Region With Malaria
Conditions: Sickle Cell Anemia;   Sickle Cell Disease;   Malaria
Interventions: Drug: Hydroxyurea;   Drug: Placebo
32 Unknown  Galectin-3 as a Biomarker in Patients With Chagas Disease
Condition: Chagas Disease.
Intervention:
33 Recruiting Low Dose Primaquine for Clearance of Gametocytes
Conditions: Malaria;   Asymptomatic Malaria;   Plasmodium Falciparum
Interventions: Drug: Artemether-lumefantrine combination;   Drug: Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine;   Drug: Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine
34 Recruiting Evaluation of Oral Activated Charcoal on the Ability of an Antimalarial Drug to Kill Parasites in Malian Children With Mild Malaria
Conditions: Malaria;   Severe Malaria
Interventions: Drug: Actidose Aqua;   Drug: Artesunate;   Drug: Amodiaquine
35 Unknown  Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
Condition: Malaria
Interventions: Biological: MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSP;   Biological: Verorab vaccine
36 Unknown  Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon
Condition: Malaria
Interventions: Drug: Artesunate-Amodiaquine;   Drug: Dihydroartemisinine-Piperaquine;   Drug: Artemether-lumefantrine combination
37 Not yet recruiting Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya
Condition: Malaria
Intervention: Device: Spatial Repellent product with active ingredient
38 Recruiting Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria
Conditions: Iron Deficiency;   Malaria;   Nutrition;   Global Health
Intervention: Dietary Supplement: Ferrous sulfate syrup; iron stable isotope 57Fe; iron stable isotope 58Fe
39 Recruiting Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia
Conditions: Malaria;   Malaria, Falciparum
Interventions: Drug: MDA with DHAp (Eurartesim);   Drug: Focal MDA with DHAp (Eurartesim)
40 Recruiting WR 279,396 for the Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Drug: WR 279,396

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years